Amneal Pharmaceuticals (AMRX) Price to FCF (2018 - 2026)

Amneal Pharmaceuticals has reported Price to FCF for 9 years, with the latest figure at 106.43 in Q2 2026.

• On a quarterly basis, Price to FCF fell 355.46% year-over-year to 106.43 in Q2 2026; TTM through Jun 2026 was 43.24, a 381.61% increase from a year earlier, with the FY2025 full-year figure at 14.69, up 45.48% from the prior year.
• Price to FCF was 106.43 for Q2 2026 at Amneal Pharmaceuticals, up from 113.56 in the prior quarter.
• The five-year high for Price to FCF was 67.71 in Q2 2024, with the low at 456.46 in Q1 2025.
• Average Price to FCF over 5 years is 33.5, with a median of 9.88 recorded in 2022.
• The largest YoY upside for Price to FCF was 266.56% in 2024 against a maximum downside of 4309.29% in 2024.
• Over 5 years, Price to FCF stood at 17.38 in 2022, then jumped by 184.96% to 14.77 in 2023, then surged by 61.51% to 23.85 in 2024, then surged by 53.12% to 36.52 in 2025, then slumped by 391.4% to 106.43 in 2026.
• The last three Price to FCF figures came in at 106.43 (Q2 2026), 113.56 (Q1 2026), and 36.52 (Q4 2025), per Business Quant data.